arXiv:2606.04339v1 Announce Type: new Abstract: Computational models of epilepsy promise patient-specific treatment design, but most optimization workflows still search for parameters that perform well on average. In neuromodulation, this is a weak target: a protocol that improves the mean response can still fail in the patient whose network is least tolerant to stimulation. We present a literature-guided minimax pipeline that couples PubMed-scale hypothesis extraction, The Virtual Brain (TVB) Epileptor simulations, and large-language-model-guided black-box optimization. The optimizer proposes
The convergence of advanced AI, large language models, and computational neuroscience tools like The Virtual Brain is enabling new frontiers in personalized medicine optimization.
This development represents a significant step towards patient-specific, AI-driven medical treatments, moving beyond 'average' responses to highly individualized care.
Clinicians will have access to optimization tools that can design neurostimulation protocols tailored to individual patient responses, potentially increasing treatment efficacy and reducing adverse outcomes.
- · Epilepsy patients
- · Computational neuroscience
- · AI in healthcare
- · Personalized medicine
- · Traditional 'trial-and-error' medical optimization
- · Generic treatment approaches
Improved efficacy and reduced side effects for epilepsy neurostimulation treatments.
Accelerated development of personalized treatment plans for other neurological and physiological conditions using similar AI-driven simulation platforms.
Ethical and regulatory frameworks will need to adapt to autonomous AI systems designing critical medical interventions, potentially leading to new oversight bodies.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG